Skip to main content
. 2016 Jun 27;7(31):50017–50026. doi: 10.18632/oncotarget.10312

Figure 2. Overall survival (OS) and Recurrence-free survival (RFS) analysis of patients with localized ccRCC based on MUC3A expression.

Figure 2

Kaplan-Meier analysis of OS A. Kaplan-Meier analysis of RFS B. P value was calculated by log-rank test.